These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34353029)

  • 1. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis.
    Permana AD; Paredes AJ; Zanutto FV; Amir MN; Ismail I; Bahar MA; Sumarheni ; Palma SD; Donnelly RF
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38745-38760. PubMed ID: 34353029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of Antialveolar Echinococcosis Efficacy of Albendazole by a Novel Nanocrystalline Formulation with Enhanced Oral Bioavailability.
    Hu C; Liu Z; Liu C; Zhang Y; Fan H; Qian F
    ACS Infect Dis; 2020 May; 6(5):802-810. PubMed ID: 31576751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
    Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
    Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
    Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
    Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Oral Bioavailability and Anti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the "Spring" and "Parachute".
    Hu C; Liu Z; Liu C; Li J; Wang Z; Xu L; Chen C; Fan H; Qian F
    Mol Pharm; 2019 Dec; 16(12):4978-4986. PubMed ID: 31613633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
    Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
    Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
    Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of Antialveolar echinococcosis efficacy of novel Albendazole-Bile acids Derivatives with Enhanced Oral Bioavailability.
    Hu C; Qin M; Zhang F; Gao R; Gan X; Du T
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011031. PubMed ID: 36595544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
    Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
    Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
    Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
    Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
    Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
    Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
    Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
    Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
    Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
    Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach.
    Labsi M; Soufli I; Khelifi L; Amir ZC; Touil-Boukoffa C
    Acta Trop; 2019 Sep; 197():105050. PubMed ID: 31170379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
    Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
    J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis.
    Gong Y; Zhou T; Ma R; Yang J; Zhao Y; Pan M; Huang Z; Wen H; Jiang H; Wang J
    BMC Infect Dis; 2024 Aug; 24(1):778. PubMed ID: 39097707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
    Wen H; Zou PF; Yang WG; Lu J; Wang YH; Zhang JH; New RR; Craig PS
    Trans R Soc Trop Med Hyg; 1994; 88(3):340-3. PubMed ID: 7974683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
    Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
    Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the Bioavailability and Anti-hepatic Alveolar Echinococcosis Effect of Albendazole-Isethionate/Hypromellose Acetate Succinate (HPMC-AS) Complex.
    Hu C; Zhang F; Fan H
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0223320. PubMed ID: 33875425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy of albendazole-loaded β-cyclodextrin against protoscoleces of Echinococcus granulosus sensu stricto.
    Bakhtiar NM; Akbarzadeh A; Ahmadpour E; Mahami-Oskouei M; Casulli A; Norouzi R; Asadi M; Ebrahimi M; Asadi N; Rodrigues Oliveira SM; de Lourdes Pereira M; Spotin A
    Exp Parasitol; 2022 Dec; 243():108428. PubMed ID: 36384195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.